Stock Rating Upgrade
The Value Trend Rating for Fresenius Medical Care AG &Co KG (NYSE: FMS) improved in recent days from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Fresenius Medical Care AG &Co KG (NYSE: FMS) stock closed at $18.38 on 8/9/24 after a modest gain of 0.7%. However, unusually low trading volume at 58% of normal accompanied the advance. The stock has declined -2.0% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
FMS’ future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be an important Value Builder.
Fresenius Medical Care AG &Co KG has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Fresenius Medical Care AG &Co KG has a very high Appreciation Score of 87 but a slightly negative Power Rating of 38, with the Positive Value Trend Rating the result.
Be the first to comment